Biohaven Pharmaceutical Holding Company Ltd (Biohaven) is a clinical-stage biopharmaceutical company. It develops late-stage product candidates for neurological diseases. The company develops small molecule CGRP receptor antagonist platform that includes two product candidates such as rimegepant for the acute treatment of migraine, and zavegepant for the prevention of a chronic and episodic migraine. Its glutamate modulation platform includes product candidates such as trigriluzole and BHV-4157 for the treatment of obsessive-compulsive disorder (OCD) and Alzheimer’s disease; BHV-0223 for the treatment of amyotrophic lateral sclerosis (ALS); and BHV-5000 for treating symptoms associated with Rett syndrome and other neuropsychiatric indications. Biohaven is headquartered in New Haven, Connecticut, the US.
Headquarters
United States of America
Address
215 Church St, New Haven, Connecticut, 06510-1803
No of Employees
928
Industry
Pharmaceuticals and Healthcare
Biohaven Pharmaceutical Holding Company Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | ARM |
| Rimegepant (BHV-3000): | NOJECTION |
| Migraine | MATES |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Biohaven Pharmaceutical Holding Company Ltd | Athersys Inc | Astellas Institute for Regenerative Medicine | Azevan Pharmaceuticals Inc | La Jolla Pharmaceutical Company |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | New Haven | Cleveland | Westborough | Bethlehem | Waltham |
| State/Province | Connecticut | Ohio | Massachusetts | Pennsylvania | Massachusetts |
| No. of Employees | 928 | 24 | - | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Vlad Coric | Chief Executive Officer; Chairman | Executive Board | - | - |
| Douglas Gray | Director; Secretary | Executive Board | - | - |
| John W. Childs | Director | Non Executive Board | - | - |
| Julia P. Gregory | Director | Non Executive Board | - | - |
| Michael T. Heffernan | Director | Non Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward